Profiling Sarcomas—The Search for a Matching Therapy
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
Learn about the types of cancer immunotherapy including immune checkpoint inhibitors, ACT, therapeutic vaccines, and more.
At a recent AACR Special Conference, experts discussed emerging therapeutic options to overcome resistance to Bacillus Calmette-Guérin (BCG).
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Learn about synthetic lethality and approved drugs that use this approach to treat cancer.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
A plenary session at the AACR Annual Meeting 2024 explored how metastases adapt to—and help shape—their new environments.
At the AACR Annual Meeting 2024, researchers discussed innovative approaches to decipher the complexities of tumor ecosystems.